Polatuzumab vedotin - CAS 1313206-42-6

Polatuzumab vedotin - CAS 1313206-42-6 Catalog number: BADC-01606

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Polatuzumab vedotin is an antibody-drug conjugate targeting CD79b. Polatuzumab vedotin has been approved for the treatment of patients with relapsed/refractory large B-cell lymphoma (LBCL).

Category
Antibody-Drug Conjugates (ADCs)
Product Name
Polatuzumab vedotin
CAS
1313206-42-6
Catalog Number
BADC-01606

Ordering Information

Catalog Number Size Price Quantity
BADC-01606 -- $--
Inquiry
Description
Polatuzumab vedotin is an antibody-drug conjugate targeting CD79b. Polatuzumab vedotin has been approved for the treatment of patients with relapsed/refractory large B-cell lymphoma (LBCL).
Appearance
Solid
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Send Inquiry
Verification code
Inquiry Basket